Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer

Yoo Hyun Song, masaki shiota, Akira Yokomizo, Takeshi Uchiumi, Keijiro Kiyoshima, Kentaro Kuroiwa, Yoshinao Oda, Seiji Naito

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: To investigate the expression and possible roles of Twist1 and Y-box-binding protein-1 (YB-1) in bladder cancer tissue. Twist1 belongs to the family of basic helix-loop-helix transcription factors. A functional link between Twist1 and YB-1 has recently been determined to play an important role in bladder cancer cell lines. Materials and methods: Frozen samples from 75 patients with bladder cancer were analyzed by quantitative real-time polymerase chain reaction (PCR). Formalin-fixed and paraffin-embedded tissues from 53 patients with bladder cancer were examined by immunohistochemistry. Results: Twist1 transcript levels were positively correlated with YB-1 transcript levels (coefficient of correlation = 0.42, P<0.001), tumor grade (low grade vs. high grade; P<0.001), invasiveness (non-muscle-invasive bladder cancer vs. muscle invasive bladder cancer; P = 0.0018), and metastasis (meta- vs. meta+; P<0.001). YB-1 transcript level was also correlated with grade (P = 0.029) and invasiveness (P = 0.006). By immunohistochemistry, Twist1 expression was also correlated with YB-1 expression (P<0.001). Further, both Twist1 and YB-1 expression were positively correlated with invasiveness (P = 0.007 and P = 0.002, respectively). Patients with high Twist1 expression and high YB-1 expression had lower overall survival rates, compared with patients with low expression (log-rank test, P = 0.040 and P<0.001, respectively). Conclusions: These results suggest a functional link between Twist1 and YB-1, and they indicate that Twist1 and YB-1 promote bladder cancer progression.

Original languageEnglish
Pages (from-to)31.e1-31.e7
JournalUrologic Oncology: Seminars and Original Investigations
Volume32
Issue number1
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Y-Box-Binding Protein 1
Urinary Bladder Neoplasms
Immunohistochemistry
Basic Helix-Loop-Helix Transcription Factors
Paraffin
Formaldehyde
Real-Time Polymerase Chain Reaction
Survival Rate
Neoplasm Metastasis
Cell Line
Muscles

All Science Journal Classification (ASJC) codes

  • Oncology
  • Urology

Cite this

Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer. / Song, Yoo Hyun; shiota, masaki; Yokomizo, Akira; Uchiumi, Takeshi; Kiyoshima, Keijiro; Kuroiwa, Kentaro; Oda, Yoshinao; Naito, Seiji.

In: Urologic Oncology: Seminars and Original Investigations, Vol. 32, No. 1, 01.01.2014, p. 31.e1-31.e7.

Research output: Contribution to journalArticle

Song, Yoo Hyun ; shiota, masaki ; Yokomizo, Akira ; Uchiumi, Takeshi ; Kiyoshima, Keijiro ; Kuroiwa, Kentaro ; Oda, Yoshinao ; Naito, Seiji. / Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer. In: Urologic Oncology: Seminars and Original Investigations. 2014 ; Vol. 32, No. 1. pp. 31.e1-31.e7.
@article{1578649f4be840b58371066d152c259e,
title = "Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer",
abstract = "Objective: To investigate the expression and possible roles of Twist1 and Y-box-binding protein-1 (YB-1) in bladder cancer tissue. Twist1 belongs to the family of basic helix-loop-helix transcription factors. A functional link between Twist1 and YB-1 has recently been determined to play an important role in bladder cancer cell lines. Materials and methods: Frozen samples from 75 patients with bladder cancer were analyzed by quantitative real-time polymerase chain reaction (PCR). Formalin-fixed and paraffin-embedded tissues from 53 patients with bladder cancer were examined by immunohistochemistry. Results: Twist1 transcript levels were positively correlated with YB-1 transcript levels (coefficient of correlation = 0.42, P<0.001), tumor grade (low grade vs. high grade; P<0.001), invasiveness (non-muscle-invasive bladder cancer vs. muscle invasive bladder cancer; P = 0.0018), and metastasis (meta- vs. meta+; P<0.001). YB-1 transcript level was also correlated with grade (P = 0.029) and invasiveness (P = 0.006). By immunohistochemistry, Twist1 expression was also correlated with YB-1 expression (P<0.001). Further, both Twist1 and YB-1 expression were positively correlated with invasiveness (P = 0.007 and P = 0.002, respectively). Patients with high Twist1 expression and high YB-1 expression had lower overall survival rates, compared with patients with low expression (log-rank test, P = 0.040 and P<0.001, respectively). Conclusions: These results suggest a functional link between Twist1 and YB-1, and they indicate that Twist1 and YB-1 promote bladder cancer progression.",
author = "Song, {Yoo Hyun} and masaki shiota and Akira Yokomizo and Takeshi Uchiumi and Keijiro Kiyoshima and Kentaro Kuroiwa and Yoshinao Oda and Seiji Naito",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.urolonc.2012.11.003",
language = "English",
volume = "32",
pages = "31.e1--31.e7",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer

AU - Song, Yoo Hyun

AU - shiota, masaki

AU - Yokomizo, Akira

AU - Uchiumi, Takeshi

AU - Kiyoshima, Keijiro

AU - Kuroiwa, Kentaro

AU - Oda, Yoshinao

AU - Naito, Seiji

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective: To investigate the expression and possible roles of Twist1 and Y-box-binding protein-1 (YB-1) in bladder cancer tissue. Twist1 belongs to the family of basic helix-loop-helix transcription factors. A functional link between Twist1 and YB-1 has recently been determined to play an important role in bladder cancer cell lines. Materials and methods: Frozen samples from 75 patients with bladder cancer were analyzed by quantitative real-time polymerase chain reaction (PCR). Formalin-fixed and paraffin-embedded tissues from 53 patients with bladder cancer were examined by immunohistochemistry. Results: Twist1 transcript levels were positively correlated with YB-1 transcript levels (coefficient of correlation = 0.42, P<0.001), tumor grade (low grade vs. high grade; P<0.001), invasiveness (non-muscle-invasive bladder cancer vs. muscle invasive bladder cancer; P = 0.0018), and metastasis (meta- vs. meta+; P<0.001). YB-1 transcript level was also correlated with grade (P = 0.029) and invasiveness (P = 0.006). By immunohistochemistry, Twist1 expression was also correlated with YB-1 expression (P<0.001). Further, both Twist1 and YB-1 expression were positively correlated with invasiveness (P = 0.007 and P = 0.002, respectively). Patients with high Twist1 expression and high YB-1 expression had lower overall survival rates, compared with patients with low expression (log-rank test, P = 0.040 and P<0.001, respectively). Conclusions: These results suggest a functional link between Twist1 and YB-1, and they indicate that Twist1 and YB-1 promote bladder cancer progression.

AB - Objective: To investigate the expression and possible roles of Twist1 and Y-box-binding protein-1 (YB-1) in bladder cancer tissue. Twist1 belongs to the family of basic helix-loop-helix transcription factors. A functional link between Twist1 and YB-1 has recently been determined to play an important role in bladder cancer cell lines. Materials and methods: Frozen samples from 75 patients with bladder cancer were analyzed by quantitative real-time polymerase chain reaction (PCR). Formalin-fixed and paraffin-embedded tissues from 53 patients with bladder cancer were examined by immunohistochemistry. Results: Twist1 transcript levels were positively correlated with YB-1 transcript levels (coefficient of correlation = 0.42, P<0.001), tumor grade (low grade vs. high grade; P<0.001), invasiveness (non-muscle-invasive bladder cancer vs. muscle invasive bladder cancer; P = 0.0018), and metastasis (meta- vs. meta+; P<0.001). YB-1 transcript level was also correlated with grade (P = 0.029) and invasiveness (P = 0.006). By immunohistochemistry, Twist1 expression was also correlated with YB-1 expression (P<0.001). Further, both Twist1 and YB-1 expression were positively correlated with invasiveness (P = 0.007 and P = 0.002, respectively). Patients with high Twist1 expression and high YB-1 expression had lower overall survival rates, compared with patients with low expression (log-rank test, P = 0.040 and P<0.001, respectively). Conclusions: These results suggest a functional link between Twist1 and YB-1, and they indicate that Twist1 and YB-1 promote bladder cancer progression.

UR - http://www.scopus.com/inward/record.url?scp=84890800267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890800267&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2012.11.003

DO - 10.1016/j.urolonc.2012.11.003

M3 - Article

C2 - 23395237

AN - SCOPUS:84890800267

VL - 32

SP - 31.e1-31.e7

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 1

ER -